Literature DB >> 27611975

Impact of Source Control in Patients With Severe Sepsis and Septic Shock.

María Luisa Martínez1, Ricard Ferrer, Eva Torrents, Raquel Guillamat-Prats, Gemma Gomà, David Suárez, Luis Álvarez-Rocha, Juan Carlos Pozo Laderas, Ignacio Martín-Loeches, Mitchell M Levy, Antonio Artigas.   

Abstract

OBJECTIVES: Time to clearance of pathogens is probably critical to outcome in septic shock. Current guidelines recommend intervention for source control within 12 hours after diagnosis. We aimed to determine the epidemiology of source control in the management of sepsis and to analyze the impact of timing to source control on mortality.
DESIGN: Prospective observational analysis of the Antibiotic Intervention in Severe Sepsis study, a Spanish national multicenter educational intervention to improve antibiotherapy in sepsis.
SETTING: Ninety-nine medical-surgical ICUs in Spain. PATIENTS: We enrolled 3,663 patients with severe sepsis or septic shock during three 4-month periods between 2011 and 2013.
INTERVENTIONS: Source control and hospital mortality.
MEASUREMENTS AND MAIN RESULTS: A total of 1,173 patients (32%) underwent source control, predominantly for abdominal, urinary, and soft-tissue infections. Compared with patients who did not require source control, patients who underwent source control were older, with a greater prevalence of shock, major organ dysfunction, bacteremia, inflammatory markers, and lactic acidemia. In addition, compliance with the resuscitation bundle was worse in those undergoing source control. In patients who underwent source control, crude ICU mortality was lower (21.2% vs 25.1%; p = 0.010); after adjustment for confounding factors, hospital mortality was also lower (odds ratio, 0.809 [95% CI, 0.658-0.994]; p = 0.044). In this observational database analysis, source control after 12 hours was not associated with higher mortality (27.6% vs 26.8%; p = 0.789).
CONCLUSIONS: Despite greater severity and worse compliance with resuscitation bundles, mortality was lower in septic patients who underwent source control than in those who did not. The time to source control could not be linked to survival in this observational database.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27611975     DOI: 10.1097/CCM.0000000000002011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  36 in total

1.  Shooting for the bull's eye in septic shock.

Authors:  Kay Choong See; Tow Keang Lim
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 2.  Treatment of severe skin and soft tissue infections: a review.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Curr Opin Infect Dis       Date:  2018-04       Impact factor: 4.915

3.  Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections.

Authors:  Laura Escolà-Vergé; Carles Pigrau; Ibai Los-Arcos; Ángel Arévalo; Belen Viñado; David Campany; Nieves Larrosa; Xavier Nuvials; Ricard Ferrer; Oscar Len; Benito Almirante
Journal:  Infection       Date:  2018-03-28       Impact factor: 3.553

4.  Vasopressor use in 41 critically ill cats (2007-2016).

Authors:  Nikki Licht; Elizabeth A Rozanski; John E Rush
Journal:  Can Vet J       Date:  2018-11       Impact factor: 1.008

5.  Bloodstream Infections and Delayed Antibiotic Coverage Are Associated With Negative Hospital Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Joyce Ji; Jeff Klaus; Jason P Burnham; Andrew Michelson; Colleen A McEvoy; Marin H Kollef; Patrick G Lyons
Journal:  Chest       Date:  2020-06-17       Impact factor: 9.410

6.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

Review 7.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

Review 8.  Skin and sepsis: contribution of dermatology to a rapid diagnosis.

Authors:  A Pulido-Pérez; E Bouza; M Bergón-Sendín; R Suárez-Fernández; P Muñoz-Martín
Journal:  Infection       Date:  2021-04-15       Impact factor: 3.553

Review 9.  Antimicrobial Treatment Duration in Sepsis and Serious Infections.

Authors:  Lindsay M Busch; Sameer S Kadri
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

10.  Emergency Department Urosepsis and Abdominal Imaging.

Authors:  Mansoor Siddiqui; Dena Abuelroos; Lihua Qu; Raymond E Jackson; David A Berger
Journal:  Cureus       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.